Master in silico drug design (ISDD) – IT

Language(s) of instruction: English

Length of study: 2 years, full time


Course Location:

  • Semester 1: Université de Strasbourg, France
  • Semester 2: Università degli Studi di Milano, Italy
  • Semester 3: Université Paris Cité, France
  • Semester 4: Placement

Degrees awarded:

  • Master Mention Bio-Informatique, Parcours : In Silico Drug Design – Bioactive Molecules, Université Paris Cité
  • Laurea Magistrale in Scienze Chimiche, Università degli Studi di Milano

Entry Requirements: Bachelor degree or international equivalent in a variety of subjects including chemistry, biochemistry, bioinformatics, biology, biotechnology, or the health sector

Language pre-requisites: B2 level of French and English

Course overview

The Master’s In Silico Drug Design was created as a result of demand from the private sector (pharmaceutical companies) and academics, in order to train students in a growing area of interest in France and Europe. The ISDD Master’s is interdisciplinary with a focus on Health Sciences. It has benefitted from the involvement of several universities, private companies and international experts in the field.

The course aims to provide training in all tasks related to Drug Discovery using silico approaches (i.e. computer assisted approaches).

Skills and competencies developed
  • Research of bioactive compounds and research in preparation for further study at doctoral level
  • Training on how to navigate the chemical elements rationally in order to facilitate the discovery of bioactive molecules necessary for an understanding of Life and the prediction of the impact of xenobiotics on humans and the environment
  • At the end of the Master’s, students should be able to participate or lead projects in silico drug design in pharmaceutical companies, medicinal chemistry companies or among sellers of chemicals or specialized software


Ms. Cédric de Cassan, administrative coordinator
Pr A-C. CAMPROUX, pedagogical coordinator